XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,844,503 | -52.0% | 53,996 | -45.9% | 0.56% | -52.9% |
| Q2 2023 | $3,840,606 | +11.0% | 99,756 | +3.2% | 1.19% | -16.8% |
| Q1 2023 | $3,458,853 | -65.4% | 96,643 | -61.9% | 1.43% | -50.1% |
| Q4 2022 | $10,001,617 | +12.6% | 253,655 | +3.1% | 2.86% | -4.8% |
| Q3 2022 | $8,880,000 | +25.5% | 245,992 | +5.7% | 3.00% | +37.9% |
| Q2 2022 | $7,077,000 | +395.6% | 232,630 | +130.1% | 2.18% | +268.7% |
| Q1 2022 | $1,428,000 | -54.3% | 101,081 | +1.1% | 0.59% | -53.3% |
| Q4 2021 | $3,124,000 | +951.9% | 100,000 | +414.6% | 1.27% | +653.6% |
| Q3 2021 | $297,000 | – | 19,432 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |